The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical implications of a prostate cancer risk SNP profile in two treatment cohorts.
Chee Leng Goh
No relevant relationships to disclose
Ed Saunders
No relevant relationships to disclose
Daniel Leongamornlert
No relevant relationships to disclose
Tokhir Dadaev
No relevant relationships to disclose
Malgorzata Tymrakiewicz
No relevant relationships to disclose
Karen Thomas
No relevant relationships to disclose
Elizabeth Selvadurai
No relevant relationships to disclose
Ruth Woode-Amissah
No relevant relationships to disclose
Nadiya Mahmud
No relevant relationships to disclose
Elena Castro
No relevant relationships to disclose
David Olmos
No relevant relationships to disclose
Michelle Guy
No relevant relationships to disclose
Koveela Govindasami
No relevant relationships to disclose
Rosemary Wilkinson
No relevant relationships to disclose
Emma Sawyer
No relevant relationships to disclose
Ali Amin Al Olama
No relevant relationships to disclose
Douglas Easton
No relevant relationships to disclose
Zsofia Kote-Jarai
No relevant relationships to disclose
Chris Parker
No relevant relationships to disclose
Ros A. Eeles
No relevant relationships to disclose